Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Wiskott-Aldrich Syndrome

• Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
• Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
• Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
• Immune Disorder HSCT Protocol
• Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
• Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
• Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)
• Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
• Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
• Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies